MANNING ANTHONY M. (Chief Scientific Officer) sold 9.9% of their position (1.61K shares) of MOMENTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $46.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/21/2020ACC: 0001179110-20-004998
Officer· Chief Scientific Officer
Since Oct 2018
-1.61K
Net shares
Net seller
$46.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.50K acquired · 5.11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.50K
Price / share
—
Trade value
—
% of position
27.4%
4/17/2020
12.76K→16.26K
Common Stock
Direct
Shares
−1.61K
Price / share
$28.96
Trade value
$46.74K
% of position
9.9%
4/20/2020
16.26K→14.64K
Total
Net shares
+1.89K
Net value
-$46.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2020 | M · Option Exercise | +3.50K | — | — | 27.4% | 12.76K | 16.26K |
| Common Stock Direct | 4/20/2020 | S · Sale | −1.61K | $28.96 | $46.74K | 9.9% | 16.26K | 14.64K |
| Total | +1.89K | -$46.74K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
3.50K shares
Shares
−3.50K
Strike price
Held after
35K
Exercisable
—
4/17/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.50K shares | 4/17/2020 | M · Option Exercise | −3.50K | — | 35K |